Codes / ICD10CM / T50.Z14

T50.Z14 Poisoning by immunoglobulin, undetermined

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by immunoglobulin, undetermined

Summary

This condition refers to poisoning resulting from exposure to immunoglobulins where the intent or circumstances of exposure are not specified. Immunoglobulins are therapeutic agents used for immune deficiencies or autoimmune conditions, but exposure can lead to adverse effects when the cause is unclear. The clinical presentation depends on the dose, route, and individual sensitivity.

Causes

Exposure may result from accidental or intentional ingestion, therapeutic errors, or adverse reactions to prescribed therapy. The undetermined nature of the exposure means the specific cause (e.g., accidental, intentional, or therapeutic error) is not documented.

Risk Factors

  • Previous allergic reactions to immunoglobulins or related products
  • Underlying immune disorders or autoimmune conditions
  • Concurrent use of medications that interact with immunoglobulin therapy
  • Elderly patients or those with impaired drug metabolism
  • Non-adherence to prescribed regimens

Symptoms

  • Fever, chills, or flu-like symptoms
  • Rash, itching, or urticaria
  • Headache, dizziness, or fatigue
  • Nausea, vomiting, or abdominal pain
  • Muscle or joint pain
  • In severe cases, anaphylaxis or hypotension

Diagnosis

Diagnosis involves patient history to identify immunoglobulin use, physical examination for signs of adverse effects, and laboratory tests to assess organ function or allergic markers. Toxicology screening may confirm exposure, but the intent or circumstances of exposure remain undetermined.

Treatment Options

  • Supportive care (e.g., hydration, monitoring)
  • Antihistamines or corticosteroids for allergic reactions
  • Management of specific symptoms (e.g., antiemetics for nausea)
  • In severe cases, advanced interventions (e.g., airway support, vasopressors)

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and individual response. Mild cases may resolve with supportive care, while severe reactions require intensive management. Follow-up includes monitoring for delayed symptoms and assessing for underlying conditions that may have contributed to exposure.

Complications

  • Anaphylaxis or severe allergic reactions
  • Organ toxicity (e.g., renal or hepatic impairment)
  • Respiratory distress or cardiovascular instability
  • Long-term immune or metabolic effects from exposure

Lifestyle & Prevention

  • Proper storage and labeling of immunoglobulin preparations
  • Education on correct administration and dosing
  • Avoidance of self-medication or misuse of therapeutic agents
  • Regular review of medication regimens to prevent errors

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning occur, such as severe allergic reactions, difficulty breathing, or altered consciousness. Prompt evaluation is critical for managing complications and determining the cause of exposure.

Tips for Medical Coders

Document the clinical context of immunoglobulin exposure, including any available details about the circumstances (e.g., accidental, intentional, or therapeutic error). If intent or circumstances are unclear, use this code to reflect the undetermined nature of the poisoning. Ensure documentation supports the diagnosis and aligns with clinical findings.

Book a walkthrough

T50.Z14 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.